Skip to content

Clinical trials

Completed Pulmonary Arterial Hypertension trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Completed Country / region: Belgium Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20051
20062
20071
20084
20096
20103
20112
20151
20161
20171
20181
20191
20214
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion10
United Therapeutics5
Bayer4
Lung Biotechnology PBC4
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Novartis Pharmaceuticals2
Altavant Sciences GmbH1
GB002, Inc.1
Gilead Sciences1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension34
Hypertension, Pulmonary13
Familial Primary Pulmonary Hypertension2
Hypertension2
Cardiovascular Diseases1
Connective Tissue Diseases1
Lung Diseases1
Respiratory Tract Diseases1
Vascular Diseases1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.